Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proline-rich coiled-coil 2C (PRRC2C) is a protein found abundantly in various tissues including adult spinal cord, liver, brain, lung, and ovary. As a key component of stress granules, PRRC2C is linked to cellular responses to stress and appears to regulate gene expression under stress conditions. Its gene is located on chromosome 1q23-24, a region often amplified in cancers. PRRC2C promotes cell proliferation, inhibits apoptosis, and enhances metastasis in multiple tumor types, mainly by upregulating EMT-related proteins like N-cadherin and Vimentin. Knockdown or silencing of PRRC2C reduces tumorigenesis in cellular and mouse models, making it a potential therapeutic and diagnostic target for hepatocellular carcinoma and possibly other cancers. Alternative splicing and mutation of PRRC2C have also been implicated in lung adenocarcinoma and Burkitt lymphoma, respectively, and PRRC2C protein is present in serum from preeclampsia patients, suggesting broader relevance beyond cancer.
no reported direct pharmacological mechanisms, but RNA interference reduces cancer cell proliferation and prompts apoptosis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proline-rich coiled-coil 2C (PRRC2C).